cDC1 prime and are licensed by CD4 T cells to induce anti-tumour immunity
暂无分享,去创建一个
Gregory F. Wu | R. Schreiber | K. Murphy | W. Gillanders | T. Murphy | J. Ward | W. Yokoyama | Derek J. Theisen | Carlos G Briseño | Lijin Li | Renee Wu | Stephen T. Ferris | V. Durai | Michael D. Bern | J. T. Davidson | Prachi Bagadia | Tiantian Liu | Carlos G. Briseño | Tian-Tian Liu
[1] Maxim N. Artyomov,et al. MHC-II neoantigens shape tumor immunity and response to immunotherapy , 2019, Nature.
[2] Howard Y. Chang,et al. Cryptic activation of an Irf8 enhancer governs cDC1 fate specification , 2019, Nature Immunology.
[3] Chun Jimmie Ye,et al. Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity , 2019, Cell.
[4] K. Crozat,et al. Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How? , 2019, Front. Immunol..
[5] Bijal A. Parikh,et al. Inducible down-regulation of MHC class I results in natural killer cell tolerance , 2018, The Journal of experimental medicine.
[6] K. Murphy,et al. Batf3-Dependent Genes Control Tumor Rejection Induced by Dendritic Cells Independently of Cross-Presentation , 2018, Cancer Immunology Research.
[7] M. Diamond,et al. WDFY4 is required for cross-presentation in response to viral and tumor antigens , 2018, Science.
[8] J. Borst,et al. CD4+ T cell help in cancer immunology and immunotherapy , 2018, Nature Reviews Immunology.
[9] N. Hacohen,et al. Monitoring T cell–dendritic cell interactions in vivo by intercellular enzymatic labelling , 2018, Nature.
[10] A. Katsarou,et al. Reporting for specific materials, systems and methods , 2018 .
[11] J. Borst,et al. CD4+ T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness , 2017, Immunity.
[12] Gordon F Heidkamp,et al. DC subset–specific induction of T cell responses upon antigen uptake via Fcγ receptors in vivo , 2017, The Journal of experimental medicine.
[13] Xiaodi Wu,et al. Mafb lineage tracing to distinguish macrophages from other immune lineages reveals dual identity of Langerhans cells , 2016, The Journal of experimental medicine.
[14] Even Fossum,et al. Broad and Largely Concordant Molecular Changes Characterize Tolerogenic and Immunogenic Dendritic Cell Maturation in Thymus and Periphery. , 2016, Immunity.
[15] S. Kaech,et al. The multifaceted role of CD4+ T cells in CD8+ T cell memory , 2016, Nature Reviews Immunology.
[16] Scott N. Mueller,et al. Spatiotemporally Distinct Interactions with Dendritic Cell Subsets Facilitates CD4+ and CD8+ T Cell Activation to Localized Viral Infection. , 2015, Immunity.
[17] Michael Y. Gerner,et al. Robust Anti-viral Immunity Requires Multiple Distinct T Cell-Dendritic Cell Interactions , 2015, Cell.
[18] E. Unanue,et al. A minor subset of Batf3-dependent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes. , 2014, Immunity.
[19] Florent Ginhoux,et al. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny , 2014, Nature Reviews Immunology.
[20] Harinder Singh,et al. Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation , 2013, Nature Communications.
[21] Gregory F. Wu,et al. Cutting Edge: Conditional MHC Class II Expression Reveals a Limited Role for B Cell Antigen Presentation in Primary and Secondary CD4 T Cell Responses , 2013, The Journal of Immunology.
[22] N. McGovern,et al. IRF4 Transcription Factor-Dependent CD11b+ Dendritic Cells in Human and Mouse Control Mucosal IL-17 Cytokine Responses , 2013, Immunity.
[23] S. Turner,et al. IRF4 Promotes Cutaneous Dendritic Cell Migration to Lymph Nodes during Homeostasis and Inflammation , 2012, The Journal of Immunology.
[24] Ansuman T. Satpathy,et al. Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages , 2012, The Journal of experimental medicine.
[25] Ton N Schumacher,et al. Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers , 2012, Nature Protocols.
[26] M. Wright,et al. The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments. , 2012, Immunity.
[27] E. Mardis,et al. Cancer Exome Analysis Reveals a T Cell Dependent Mechanism of Cancer Immunoediting , 2012, Nature.
[28] L. Sherman,et al. CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes. , 2010, Cancer research.
[29] M. Nussenzweig,et al. Route of Antigen Uptake Differentially Impacts Presentation by Dendritic Cells and Activated Monocytes , 2010, The Journal of Immunology.
[30] K. Murphy,et al. Critical role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis , 2008, Nature.
[31] E. Unanue,et al. Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity , 2008, Science.
[32] Gordon D. Brown,et al. CLEC9A Is a Novel Activation C-type Lectin-like Receptor Expressed on BDCA3+ Dendritic Cells and a Subset of Monocytes , 2008, Journal of Biological Chemistry.
[33] R. Steinman,et al. Differential Antigen Processing by Dendritic Cell Subsets in Vivo , 2007, Science.
[34] J. Cyster,et al. Naive CD4 T cells constitutively express CD40L and augment autoreactive B cell survival. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[35] A. Tyznik,et al. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells , 2006, Nature.
[36] T. Schumacher,et al. Design and use of conditional MHC class I ligands , 2006, Nature Medicine.
[37] Stephen P. Schoenberger,et al. CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death , 2005, Nature.
[38] C. Ware,et al. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator , 2005, Nature Immunology.
[39] Gabrielle T Belz,et al. Cognate CD4+ T cell licensing of dendritic cells in CD8+ T cell immunity , 2004, Nature Immunology.
[40] M. Bevan,et al. CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection , 2004, Nature Immunology.
[41] M. Bevan,et al. Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help , 2003, Science.
[42] H. Virgin,et al. Virus subversion of the MHC class I peptide-loading complex. , 2003, Immunity.
[43] B. Rocha,et al. A Role for CD40 Expression on CD8+ T Cells in the Generation of CD8+ T Cell Memory , 2002, Science.
[44] M. Winslow,et al. Major Histocompatibility Complex Class II Presentation of Cell-associated Antigen Is Mediated by CD8α+ Dendritic Cells In Vivo , 2002, The Journal of experimental medicine.
[45] K. Hashimoto,et al. A conditional null allele of the major histocompatibility IA‐beta chain gene , 2002, Genesis.
[46] Shankar Srinivas,et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus , 2001, BMC Developmental Biology.
[47] R. Zinkernagel,et al. FTY720 Immunosuppression Impairs Effector T Cell Peripheral Homing Without Affecting Induction, Expansion, and Memory1 , 2000, The Journal of Immunology.
[48] Polly Matzinger,et al. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell , 1998, Nature.
[49] Richard A. Flavell,et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling , 1998, Nature.
[50] Stephen P. Schoenberger,et al. T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions , 1998, Nature.
[51] W. Heath,et al. Induction of a CD8+ Cytotoxic T Lymphocyte Response by Cross-priming Requires Cognate CD4+ T Cell Help , 1997, The Journal of experimental medicine.